|Mr. Bang Chen||Founder & Chairman||N/A||N/A||1965|
|Mr. Li Li||Vice Chairman & Deputy GM||N/A||N/A||1965|
|Mr. Duoyuan Liu||Chief Financial Officer||N/A||N/A||1962|
|Mr. Zhong Han||Deputy GM & Director||N/A||N/A||1965|
|Mr. Shibo Tang||Deputy Gen. Mang.||N/A||N/A||1961|
|Mr. Aiming Li||Deputy Gen. Mang.||N/A||N/A||1970|
|Mr. Wei Wan||Deputy Gen. Mang.||N/A||N/A||1969|
|Mr. Shi Jun Wu||Sec. & Director||N/A||N/A||1972|
|Qiang Huang||Representative of Stock Affairs||N/A||N/A||N/A|
Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. The company operates approximately 500 ophthalmic hospitals in mainland China, 86 ophthalmic hospitals in Europe, 1 ophthalmic hospital in the United States, 7 ophthalmic hospitals in Hong Kong, and 12 ophthalmic hospitals in Southeast Asia. The company was founded in 2007 and is headquartered in Changsha, China.
Aier Eye Hospital Group Co., Ltd.’s ISS governance QualityScore as of 1 July 2021 is 2. The pillar scores are Audit: 3; Board: 7; Shareholder rights: 1; Compensation: 8.